Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study.

PubWeight™: 4.27‹?› | Rank: Top 1%

🔗 View Article (PMID 10601381)

Published in J Natl Cancer Inst on December 15, 1999

Authors

I M Lee1, N R Cook, J E Manson, J E Buring, C H Hennekens

Author Affiliations

1: Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, and Boston, MA 02215, USA. i-min.lee@channing.harvard.edu

Associated clinical trials:

Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer (WHS) | NCT00000479

Articles citing this

Dietary supplements and mortality rate in older women: the Iowa Women's Health Study. Arch Intern Med (2011) 6.69

Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 5.13

Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2012) 4.40

A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med (2007) 3.37

Reactive oxygen species in cardiovascular disease. Free Radic Biol Med (2011) 2.29

Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation (2009) 2.26

Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. J Natl Cancer Inst (2008) 2.07

Beta-carotene: a miss for epidemiology. J Natl Cancer Inst (1999) 2.07

Alcohol consumption, weight gain, and risk of becoming overweight in middle-aged and older women. Arch Intern Med (2010) 1.85

Dual Association of beta-carotene with risk of tobacco-related cancers in a cohort of French women. J Natl Cancer Inst (2005) 1.79

Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study. Am J Epidemiol (2009) 1.63

Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women. Ophthalmology (2009) 1.62

Serum antioxidant nutrients, vitamin A, and mortality in U.S. Adults. Cancer Epidemiol Biomarkers Prev (2013) 1.58

Alcohol consumption and risk of incident atrial fibrillation in women. JAMA (2008) 1.55

Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study. BMJ (2007) 1.40

Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment. Clin Cancer Res (2013) 1.30

Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women. Am J Clin Nutr (2009) 1.24

Socioeconomic status and incident type 2 diabetes mellitus: data from the Women's Health Study. PLoS One (2011) 1.21

Astaxanthin: a potential therapeutic agent in cardiovascular disease. Mar Drugs (2011) 1.19

Alcohol consumption and risk of cardiovascular disease and death in women: potential mediating mechanisms. Circulation (2009) 1.18

Serum carotenoids and vitamins in relation to markers of endothelial function and inflammation. Eur J Epidemiol (2004) 1.15

Vitamin and mineral supplements: do we really need them? Int J Prev Med (2012) 1.14

A randomized trial of low-dose aspirin in the prevention of clinical type 2 diabetes in women. Diabetes Care (2008) 1.13

Fruit and vegetable intake and the risk of hypertension in middle-aged and older women. Am J Hypertens (2011) 1.11

Associations of plasma carotenoids with risk factors and biomarkers related to cardiovascular disease in middle-aged and older women. Am J Clin Nutr (2008) 1.10

Evaluation of Antioxidant Properties of Phaulopsis fascisepala C.B.Cl. (Acanthaceae). Evid Based Complement Alternat Med (2007) 1.10

Citrus fruit intake and stomach cancer risk: a quantitative systematic review. Gastric Cancer (2008) 1.09

Metabolic syndrome, inflammation, and risk of symptomatic peripheral artery disease in women: a prospective study. Circulation (2009) 1.08

The Antioxidants in Prevention of Cataracts Study: effects of antioxidant supplements on cataract progression in South India. Br J Ophthalmol (2006) 1.02

Marine carotenoids: biological functions and commercial applications. Mar Drugs (2011) 1.02

Diet, smoking and lung cancer: a case-control study of 1000 cases and 1500 controls in South-West England. Br J Cancer (2001) 1.02

Plasma and dietary antioxidant status as cardiovascular disease risk factors: a review of human studies. Nutrients (2013) 1.02

Effect of antioxidant vitamin supplementation on cardiovascular outcomes: a meta-analysis of randomized controlled trials. PLoS One (2013) 0.96

Endothelial cell-specific reactive oxygen species production increases susceptibility to aortic dissection. Circulation (2014) 0.93

Antioxidant vitamin supplementation for preventing and slowing the progression of age-related cataract. Cochrane Database Syst Rev (2012) 0.92

Vitamin E in the primary prevention of rheumatoid arthritis: the Women's Health Study. Arthritis Rheum (2008) 0.91

Epidemiological and clinical studies of nutrition. Semin Oncol (2010) 0.91

Dietary fatty acids and the risk of hypertension in middle-aged and older women. Hypertension (2010) 0.91

Nox4-dependent ROS modulation by amino endoperoxides to induce apoptosis in cancer cells. Cell Death Dis (2013) 0.90

Beta carotene supplementation and age-related maculopathy in a randomized trial of US physicians. Arch Ophthalmol (2007) 0.89

Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 0.88

On enzyme-based anticancer molecular dietary manipulations. J Biomed Biotechnol (2012) 0.86

Natural products for cancer prevention. Semin Oncol Nurs (2012) 0.86

Antioxidant vitamins and the risk of endometrial cancer: a dose-response meta-analysis. Cancer Causes Control (2008) 0.84

Erythrocyte fatty acid composition is associated with the risk of hypertension in middle-aged and older women. J Nutr (2011) 0.84

Increased dietary intake of vitamin A promotes aortic valve calcification in vivo. Arterioscler Thromb Vasc Biol (2012) 0.83

Effects of exogenous antioxidants on dietary iron overload. J Clin Biochem Nutr (2008) 0.82

Effects of α-tocopherol and β-carotene supplementation on cancer incidence and mortality: 18-year postintervention follow-up of the Alpha-tocopherol, Beta-carotene Cancer Prevention Study. Int J Cancer (2013) 0.82

Vitamin A/retinol and maintenance of pluripotency of stem cells. Nutrients (2014) 0.82

Dietary supplements and disease prevention - a global overview. Nat Rev Endocrinol (2016) 0.81

Vitamin E supplementation and the risk of heart failure in women. Circ Heart Fail (2012) 0.81

Chloroform Fraction of Centratherum anthelminticum (L.) Seed Inhibits Tumor Necrosis Factor Alpha and Exhibits Pleotropic Bioactivities: Inhibitory Role in Human Tumor Cells. Evid Based Complement Alternat Med (2012) 0.81

A prospective study of erythrocyte polyunsaturated fatty acid, weight gain, and risk of becoming overweight or obese in middle-aged and older women. Eur J Nutr (2015) 0.81

Vitamin E and age-related macular degeneration in a randomized trial of women. Ophthalmology (2010) 0.80

Vitamin A and retinoid derivatives for lung cancer: a systematic review and meta analysis. PLoS One (2011) 0.80

Validation of the FSA nutrient profiling system dietary index in French adults-findings from SUVIMAX study. Eur J Nutr (2015) 0.79

Updates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemoprevention. Cancers (Basel) (2014) 0.79

Migraine and cardiovascular disease in women and the role of aspirin: subgroup analyses in the Women's Health Study. Cephalalgia (2011) 0.79

Total and individual antioxidant intake and endometrial cancer risk: results from a population-based case-control study in New Jersey. Cancer Causes Control (2012) 0.78

Are antioxidants helpful for disease prevention? Res Pharm Sci (2010) 0.78

Randomised beta-carotene supplementation and incidence of cancer and cardiovascular disease in women: is the association modified by baseline plasma level? Br J Cancer (2002) 0.77

Barriers to preventive therapy for breast and other major cancers and strategies to improve uptake. Ecancermedicalscience (2015) 0.77

Supplementation of adult rats with moderate amounts of β-carotene modulates the redox status in plasma without exerting pro-oxidant effects in the brain: a safer alternative to food fortification with vitamin A? Nutrients (2014) 0.77

Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles. Redox Biol (2016) 0.76

Antioxidants and cardiovascular disease: Still a topic of interest. Environ Health Prev Med (2004) 0.76

Effects of Vitamin and Antioxidant Supplements in Prevention of Bladder Cancer: a Meta-Analysis of Randomized Controlled Trials. J Korean Med Sci (2017) 0.75

Strength Training and the Risk of Type 2 Diabetes and Cardiovascular Disease. Med Sci Sports Exerc (2016) 0.75

Dietary Supplements and Risk of Cause-Specific Death, Cardiovascular Disease, and Cancer: A Systematic Review and Meta-Analysis of Primary Prevention Trials. Adv Nutr (2017) 0.75

Chemoprevention in gastrointestinal physiology and disease. Targeting the progression of cancer with natural products: a focus on gastrointestinal cancer. Am J Physiol Gastrointest Liver Physiol (2016) 0.75

On the Occasion of World Cancer Day 2015; the Possibility of Cancer Prevention or Treatment with Antioxidants: The Ongoing Cancer Prevention Researches. Int J Prev Med (2015) 0.75

Articles by these authors

Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol (1985) 26.13

Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet (1990) 24.72

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med (2000) 18.04

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA (2001) 15.85

Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med (2001) 14.48

The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08

Body weight and mortality among women. N Engl J Med (1995) 11.04

Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol (1986) 10.84

Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol (1994) 9.90

Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J (1985) 9.28

Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med (2000) 9.05

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med (1991) 8.66

Annual deaths attributable to obesity in the United States. JAMA (1999) 8.62

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA (1995) 8.60

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med (1996) 8.57

Test of the National Death Index. Am J Epidemiol (1984) 8.46

Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med (1997) 8.43

Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA (1989) 8.36

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation (2000) 8.17

The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health (1997) 8.00

Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet (1991) 7.87

Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med (1995) 7.62

Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA (1998) 7.09

Plasma organochlorine levels and the risk of breast cancer. N Engl J Med (1997) 7.02

Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA (1997) 6.92

An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation (1989) 6.87

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science (1998) 6.50

The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med (2001) 6.37

Abdominal adiposity and coronary heart disease in women. JAMA (1998) 6.21

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med (1991) 6.13

A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med (1990) 6.06

Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med (2001) 5.90

Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med (2000) 5.63

Vitamin E consumption and the risk of coronary disease in women. N Engl J Med (1993) 5.39

The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol (1988) 5.32

Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study. JAMA (1993) 5.31

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst (1999) 5.27

Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med (1993) 5.19

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med (2000) 5.17

Birthweight as a risk factor for breast cancer. Lancet (1996) 5.05

Intake of trans fatty acids and risk of coronary heart disease among women. Lancet (1993) 5.00

Postmenopausal hormone therapy and mortality. N Engl J Med (1997) 4.96

A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med (1995) 4.94

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation (1998) 4.89

Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol (1997) 4.84

Baseline characteristics of participants in the Women's Health Study. J Womens Health Gend Based Med (2000) 4.84

Dual effects of weight and weight gain on breast cancer risk. JAMA (1997) 4.81

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation (1998) 4.80

Dietary fat and fiber in relation to risk of breast cancer. An 8-year follow-up. JAMA (1992) 4.80

Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA (1995) 4.78

Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (1998) 4.74

Menopause and the risk of coronary heart disease in women. N Engl J Med (1987) 4.70

Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst (1996) 4.66

Weight as a risk factor for clinical diabetes in women. Am J Epidemiol (1990) 4.64

A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med (1999) 4.61

A prospective study of passive smoking and coronary heart disease. Circulation (1997) 4.51

A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA (1997) 4.50

Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. BMJ (1997) 4.49

Birthweight and the risk for type 2 diabetes mellitus in adult women. Ann Intern Med (1999) 4.49

Cigarette smoking, relative weight, and menopause. Am J Epidemiol (1983) 4.46

Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study. JAMA (1999) 4.43

A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr (2000) 4.38

Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. JAMA (1997) 4.37

Smoking cessation and decreased risk of stroke in women. JAMA (1993) 4.36

Pharmacotherapy for obesity -- do the benefits outweigh the risks? N Engl J Med (1996) 4.32

PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet (1997) 4.27

Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr (2001) 4.26

Alcohol consumption and mortality among women. N Engl J Med (1995) 4.22

Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann Epidemiol (2000) 4.21

Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study. Osteoporos Int (2012) 4.09

Fruit and vegetable intake and risk of cardiovascular disease: the Women's Health Study. Am J Clin Nutr (2000) 3.99